Universita' Degli Studi G. D'annunzio Di Chieti — Clinical Trial Site

62 Registered trials

20 Currently recruiting

Organisation

Universita' Degli Studi G. D'annunzio Di Chieti

Location

Chieti Scalo, Italy

Identifier

ORG-100010711

Address

Via Luigi Polacchi 11, 66100, Italy

Departments

Ambulatorio di Medicina Vascolare, Medicina Generale II
Cardiology
Cardiology Unit - SS. Annunziata Hospital
CAST - Center for Advanced Studies and Technology
CAST (Center of Advanced Study and Technology) – Clinical Research Center
Center for Advanced Studies and Technology - Clinical Research Center
Center for Advanced Studies and Technology (CAST) – CRC
Center for advanced studies and tecnology
Centro di Ricerca Clinica
Centro di Ricerca Clinica (CRC) del Centro Studi e Tecnologie Avanzate
Centro di Studi e tecnologie avanzate
Centro di Studi e Tecnologie Avanzate - Center for Advanced Studies And Technology - CAST
Centro Scienze dell'Invecchiamento (Centro Studi Sull'Invecchiamento (Ce.S.I.)
Clinica neurologica
Clinica Oncologica
Clinical research Center - CAST
Deparment of Neuroscience, Imaging and Clinical Sciences
Department of Neuroscience, Imaging and Clinical Sciences
Department of Neuroscience, Imaging and Medical Sciences
Department of Neurosciences, Imaging and Clinical Sciences, School of Medicine
Department of Neurosciences, Imaging, and Clinical Sciences
Dept od Medicine and Ageing Sciences
Dermatology
DIPART. MEDICINA E SCIENZE INVECCHIAMENTO C/O CAST
Dipartimento di Dermatologia
Dipartimento di Neuroscienze, Imaging e Scienze Cliniche
Dipartimento di Pediatria
Dipartimento di Tecnologie Innovative in Medicina e Odontoiatria
Istituto di Tecnologie Avanzate Biomediche (ITAB), Dip. di Neuroscience, Imaging e Scienze Cliniche
Medicina Interna
N/A
NA
Nefrologia e Dialisi
Nephrology
Neurologia
Neurology
Neurology Department
Neuroscience, Imaging and Clinical Sciences
Neuroscienze
Oncologia Medica
SOC Radioterapia Oncologica
Unit Dermatology
UOC Clinica Oncologica
UOC Riabilitazione Visiva Chirurgica
Vascular Surgery
Via dei Vestini, 5, UOC Urologia, Chieti, 66100, IT

Clinical trials at this site (62)

Search interface

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson’s Disease Pending

2024-515448-22-00 Parkinson 4
Evaluation of the efficacy and safety of Magnetic Resonance Angiography (MRA) using gadopiclenol compared to gadoterate meglumine in the ass… Pending

2024-518835-13-00 Suspected Vascular Disease of supra-aortic (carotid/ver 5
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults with Type 2 D… Pending

2024-520068-32-00 Type 2 diabetes 6
Study on the use of colchicine to reduce inflammation after deep vein thrombosis Pending

2025-521836-12-00 deep vein thrombosis 4
ARMYDA - 10 study Pending

2025-523977-40-00 non-ST-elevation myocardial infarction (NSTEMI); unstab 6
A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Pending

2025-524316-11-00 Primary Progressive Multiple Sclerosis (PPMS) 5
Long-Term Safety Study of Deucravacitinib versus Ustekinumab in Participants with Psoriasis (PRAGMATYK) Recruiting

2023-503766-24-00 Moderate to Severe Plaque Psoriasis 11 2026-05-26
COLCOT-T2D Recruiting

2024-516646-19-00 Type 2 diabetic patients with no prior cardiovascular ( 5 2025-08-15
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized cli… Recruiting

2024-514732-24-00 Juvenile idiopathic arthritis 6 2025-04-28
Selective Treatment of Oral Povorcitinib in Prurigo Nodularis Study 1 (STOP-PN1) Recruiting

2024-511879-16-00 Prurigo Nodularis 5 2024-12-12
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Recruiting

2023-504358-36-00 multiple sclerosis 5 2024-10-17
A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 1… Recruiting

2023-508099-12-00 Dermatitis atopic 5 2024-06-20
Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alz… Recruiting

2022-503148-41-00 Alzheimer's disease 4 2023-12-01
Long-Term Safety and Efficacy evaluation of amlitelimab in participants of previous amlitelimab moderate to severe atopic dermatitis clinica… Recruiting

2023-506548-18-00 Dermatitis atopic 10 2022-11-10
Pilot Study to Evaluate Safety and Efficacy of PolyCore, a Ternary Combination of Xylitol, L-Carnitine and Polydextrin, to Treat End-Stage K… Recruiting

2024-519366-52-00 End-Stage Kidney Disease 4 2026-02-17
A study to compare different doses of RO7268489 with a placebo (as add-on therapy to ocrelizumab) in people with multiple sclerosis that has… Recruiting

2025-521636-10-00 Progressive Forms of Multiple Sclerosis (PMS) 4 2026-02-04
Psilocybin versus Personalized Neuromodulation for Resistant Depression (PSILO-MODULATION) Recruiting

2024-519844-34-03 Treatment Resistant Depression (TRD) 4 2026-01-19
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid… Recruiting

2025-520564-17-00 Hidradenitis suppurativa (HS) 5 2025-10-16
Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD Recruiting

2024-512091-35-01 Peripheral arterial disease 5 2025-06-17
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
Peritoneal Ultrafiltration in Cardio Renal Syndrome to Prevent Heart Failure Exacerbation (PURE) Recruiting

2024-512658-41-00 Congestive Heart Failure 10 2024-03-06
An Open-label Study of XEN1101 in Epilepsy Recruiting

2022-502282-24-00 Primary generalized tonic-clonic seizures 5 2024-02-14